Network Pharmacology Analysis of Glycyrrhetinic Acid in Metabolic Dysfunction-Associated Steatotic Liver Disease.
- DOI
- 10.3390/metabo16050301
- Published
- 2026 Apr 29
- Container
- Metabolites
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/metabo16050301,
title = {Network Pharmacology Analysis of Glycyrrhetinic Acid in Metabolic Dysfunction-Associated Steatotic Liver Disease.},
author = {Jaramillo-Morales OA and Cruz-Trujillo R and De la Torre-Sosa CN and Corzo-Gómez JC and Domínguez-Cruz DC and Cruz-Cadena RE and Vega-Cabrera NV and Espinosa-Juárez JV},
year = {2026},
journal = {Metabolites},
doi = {10.3390/metabo16050301},
url = {https://doi.org/10.3390/metabo16050301}
}RIS
TY - JOUR TI - Network Pharmacology Analysis of Glycyrrhetinic Acid in Metabolic Dysfunction-Associated Steatotic Liver Disease. AU - Jaramillo-Morales OA AU - Cruz-Trujillo R AU - De la Torre-Sosa CN AU - Corzo-Gómez JC AU - Domínguez-Cruz DC AU - Cruz-Cadena RE AU - Vega-Cabrera NV AU - Espinosa-Juárez JV PY - 2026 JO - Metabolites DO - 10.3390/metabo16050301 UR - https://doi.org/10.3390/metabo16050301 ER -
APA
OA, J., R, C., CN, D. L. T., JC, C., DC, D., RE, C., NV, V., & JV, E. (2026). Network Pharmacology Analysis of Glycyrrhetinic Acid in Metabolic Dysfunction-Associated Steatotic Liver Disease.. Metabolites. https://doi.org/10.3390/metabo16050301
Source records
- pubmed · retrieved 2026-09-27T15:02:09.252Z